Login / Signup

Efficacy and safety of low dose, weight-based subcutaneous enoxaparin protocol in recurrent arteriovenous access thrombosis.

Chye Chung GanRu Yu TanMay Anne CheongSuh Chien PangRen Kwang Alvin TngChee Wooi TanLai Heng LeeHeng Joo NgKiang Hiong TayTze Tec ChongChieh-Suai Tan
Published in: The journal of vascular access (2023)
SEP appears to be a feasible and safe thromboprophylaxis method to improve thrombosis-free patency for AV access with recurrent thrombosis.
Keyphrases
  • pulmonary embolism
  • low dose
  • venous thromboembolism
  • randomized controlled trial
  • body mass index
  • physical activity
  • high dose
  • weight loss
  • direct oral anticoagulants
  • weight gain
  • atrial fibrillation